FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SCHULER JACK W 		2. Issuer Name and Ticker or Trading Symbol

BIOLASE, INC [ BIOL ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

100 N. FIELD DRIVE, SUITE 360 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/29/2016
(Street)

LAKE FOREST, IL 60045
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   12/29/2016     P    2200   A $1.4073   (2) 10197399   I   By Trust   (1)
Common Stock   12/30/2016     P    8002   A $1.3902   (3) 10205401   I   By Trust   (1)
Common Stock   1/3/2017     P    9100   A $1.4446   (4) 10214501   I   By Trust   (1)
Common Stock   1/4/2017     P    24255   A $1.5231   (5) 10238756   I   By Trust   (1)
Common Stock                  100000   I   By Spouse  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  These shares of Common Stock ("Shares") are held by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.
(2)  This price reflects the weighted average purchase price for open-market purchases of shares of Shares made by the Reporting Persons on December 29, 2016, within a $1.00 range. The actual prices for these transactions range from $1.395 to $1.42, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2), (3), (4), and (5) to this Form 4.
(3)  This price reflects the weighted average purchase price for open-market purchases of shares of Shares made by the Reporting Persons on December 30, 2016, within a $1.00 range. The actual prices for these transactions range from $1.39 to $1.40, inclusive.
(4)  This price reflects the weighted average purchase price for open-market purchases of shares of Shares made by the Reporting Persons on January 3, 2017, within a $1.00 range. The actual prices for these transactions range from $1.425 to $1.46, inclusive.
(5)  This price reflects the weighted average purchase price for open-market purchases of shares of Shares made by the Reporting Persons on January 4, 2017, within a $1.00 range. The actual prices for these transactions range from $1.50 to $1.53, inclusive.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SCHULER JACK W
100 N. FIELD DRIVE
SUITE 360
LAKE FOREST, IL 60045
X

Jack W. Schuler Living Trust
100 NORTH FIELD DRIVE
SUITE 360
LAKE FOREST, IL 60045
X


Signatures
/s/ Jack W. Schuler, as self and as Trustee of the Jack W. Schuler Living Trust 7/13/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Biolase (NASDAQ:BIOL)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Biolase Charts.
Biolase (NASDAQ:BIOL)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Biolase Charts.